China In Vitro Diagnostics (IVD) Market Examined by Renub Research in Topical Study Available at MarketPublishers.com
11 Dec 2014 • by Natalie Aster
LONDON – Today, the Chinese market for In Vitro Diagnostics (IVD) shows stable growth and is one of the most rapidly evolving IVD markets worldwide. Besides, the market for IVD in China is predicted to increase significantly by 2018, representing twofold growth from 2013.
The immunoassay segment holds the largest share of the total IVD market, followed by the clinical chemistry segment. Despite the YoY growth of the clinical chemistry segment, its share is decreasing each year. The molecular diagnostics share also demonstrates high YoY growth and holds the 3rd position in the IVD market.
The growing government funding, technological advancements along with the on-going improvements of healthcare facilities are the main factors propelling further market expansion. Furthermore, the rising patient awareness, rising incidence of self-testing and baby booming population are also driving the IVD market.
ADICON Clinical Laboratories, Zhejiang Di’an Diagnostics Technology, Guangzhou, BGI–Shenzhen, OriGene Technologies and Kindstar Global are amid the main Chinese IVD market players today. Meantime, Roche holds the largest share in the Chinese IVD market.
Topical market research report “China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis” developed by Renub Research delves into the Chinese IVD market landscape.
The comprehensive study includes wealth of important data on the IVD market performance in China and offers details on the market development since 2007. The in-demand report reviews the main segments of the IVD market, discusses the recent developments, including the state reforms and policies. Moreover, it analyses the regulatory environment in China and traces the prevailing trends. Key factors, encouraging the market growth, along with the major challenges are described, too. Besides, the study comprises an all-round examination of the main manufacturers and gives updated information on their sales. Private clinical labs and diagnostic services companies are described as well. Future prospects of the IVD market in China are also unveiled in the report.
China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis
Published: December, 2014
Price: US$ 1,400.00
More topical reports by the publisher can be found at Renub Research page.